'Nonsensical': Califf Blasts FDA Workforce Cuts

'Nonsensical': Califf Blasts FDA Workforce Cuts

(MedPage Today) -- In part two of this "Exit Interviews" conversation, MedPage Today editor-in-chief Jeremy Faust, MD, continues his discussion with former FDA Commissioner Robert Califf, MD. Califf addresses the fallout from the mass layoffs...

Crucial FDA drug reviews expected to be slowed by job cuts

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

Biotech CEOs, VCs urge Cassidy, Senate to ease impact of FDA cuts

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical institutional knowledge at the FDA.

Rep. Jamie Raskin, lawmakers seek ‘urgent meeting’ over deep cuts at Maryland-based FDA

WASHINGTON — Democratic Rep. Jamie Raskin and other Maryland lawmakers are seeking an “urgent meeting” with the Maryland-based Food and Drug Administration’s new commissioner over deep cuts that lawmakers fear could undermine its mission, including its response to the bird…

As FDA slashes workforce, number of new medical devices reaching the public has fallen

U.S. Food and Drug Administration approvals of life-changing, high-risk medical devices reportedly slowed to a 10-year low for the January to March period, as sources say recent layoffs have had devastating effects.

High-risk medical device approvals reportedly slow as FDA slashes workforce

The lower number of reported decisions is occurring despite more pending applications for these high-risk devices.